Virios Therapeutics (VIRI) Reports Q1 Loss of $0.37

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. AAPL
6. MRVL
7. CL
8. TFII
9. ORCL
10. LYB

Go back to Virios Therapeutics (VIRI) Reports Q1 Loss of $0.37

Virios Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update

May 13, 2021 7:05 AM EDT

ATLANTA--(BUSINESS WIRE)-- Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, today reported financial results for the first quarter ended March 31, 2021.

Our team has made significant operational progress to ensure the commencement of our landmark Phase 2b fibromyalgia clinical trial,... More